Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutationsHanako Hasegawa, Kenzo Soejima, Tetsuo Tani et al.|Lung Cancer|2018Cited by 50
Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case reportTetsuo Tani, Tomoko Betsuyaku, Katsuhiko Naoki et al.|Molecular and Clinical Oncology|2016Cited by 7